Abstract:Background: Hypoxic-ischaemic encephalopathy (HIE) is a major cause of neonatal disability and mortality. Although hypothermia therapy offers some neuroprotection, the recovery of neurological function is limited. Therefore, new synergistic therapies are necessary to improve the prognosis. Mesenchymal stem cell-based therapy is emerging as a promising treatment option for HIE. In this study, we studied the therapeutic efficacy of human placenta-derived mesenchymal stem cells (PD-MSCs) in the HIE rat model and analyzed the underlying therapeutic mechanisms. Methods: Rats were divided into 6 groups (n = 9 for each) as follows: control, HIE model, HIE + normal saline, and HIE + PD-MSC transplantation at days 7, 14 and 28 postpartum. Following PD-MSC transplantation, neurological behavior was evaluated using rotarod tests, traction tests, and the Morris water maze test. The degree of brain tissue damage was assessed by histological examination and Nissl staining. Expression levels of apoptosis-related proteins and inflammatory factors were quantified by Western blotting and enzyme-linked immunosorbent assays. Immunofluorescence was used to investigate the ability of PD-MSCs to repair the morphology and function of hippocampal neurons with hypoxic-ischaemic (HI) injury. Results: PD-MSC transplantation enhanced motor coordination and muscle strength in HIE rats. This treatment also improved spatial memory ability by repairing pathological damage and preventing the loss of neurons in the cerebral cortex. The most effective treatment was observed in the HIE + PD-MSC transplantation at day 7 group. Expression levels of microtubule-associated protein-2 (MAP-2), B-cell lymphoma-2 (BCL-2), interleukin (IL)-10, and transforming growth factor (TGF -β1) were significantly higher in the HIE + PD-MSC treatment groups compared to the HIE group, whereas the levels of BCL-2-associated X protein (BAX), BCL-2-associated agonist of cell death (BAD), IL-1β and tumour necrosis factor α (TNF-α) were significantly lower. Conclusions: We demonstrated that intravenous injection of PD-MSC at 7, 14 and 28 days after intrauterine HI damage in a rat model could improve learning, memory, and motor function, possibly by inhibiting apoptosis and inflammatory damage. These findings indicate that autologous PD-MSC therapy could have potential application for the treatment of HIE.

The fate and prospects of stem cell therapy in the treatment of hypoxic‐ischemic encephalopathy

Human Neural Stem Cell Grafts Modify Microglial Response and Enhance Axonal Sprouting in Neonatal Hypoxic–Ischemic Brain Injury

Stem Cells in Central Nervous System Diseases: Promising Therapeutic Strategies.

Inducible pluripotent stem cells for the treatment of ischemic stroke: current status and problems.

Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies

Advances in mesenchymal stem cell-centered stem cell therapy in the treatment of hypoxic-ischemic injury

Current analysis of hypoxic-ischemic encephalopathy research issues and future treatment modalities

Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage.

Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy

Stem Cell Therapy in Neonatal Hypoxic-Ischemic Encephalopathy and Cerebral Palsy: a Bibliometric Analysis and New Strategy

A Visualization Analysis of Current Research on Stem Cell Transplantation in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy

Mechanism and Treatment Related to Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy

Narrative Review of Stem Cell Therapy for Ischemic Brain Injury.

Neuroprotection of Stem Cells Against Ischemic Brain Injury: From Bench to Clinic

Preconditioned Stem Cells: A Promising Strategy for Cell-Based Ischemic Stroke Therapy

Emerging therapeutic strategies in hypoxic-ischemic encephalopathy: a focus on cognitive outcomes

Transplanted Deep-Layer Cortical Neuroblasts Integrate into Host Neural Circuits and Alleviate Motor Defects in Hypoxic-Ischemic Encephalopathy Injured Mice

Human Placenta-Derived Mesenchymal Stem Cells Improve Neurological Function in Rats with Intrauterine Hypoxic-Ischaemic Encephalopathy by Reducing Apoptosis and Inflammatory Reactions

Emerging strategies for nerve repair and regeneration in ischemic stroke: neural stem cell therapy

Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy